Rua Bioscience Ltd
NZX:RUA

Watchlist Manager
Rua Bioscience Ltd Logo
Rua Bioscience Ltd
NZX:RUA
Watchlist
Price: 0.03 NZD Market Closed
Market Cap: 8.6m NZD
Have any thoughts about
Rua Bioscience Ltd?
Write Note

Rua Bioscience Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Rua Bioscience Ltd
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Rua Bioscience Ltd
NZX:RUA
Operating Income
-NZ$4.6m
CAGR 3-Years
10%
CAGR 5-Years
-18%
CAGR 10-Years
N/A
BLIS Technologies Ltd
NZX:BLT
Operating Income
NZ$910k
CAGR 3-Years
16%
CAGR 5-Years
18%
CAGR 10-Years
N/A
A
AFT Pharmaceuticals Ltd
NZX:AFT
Operating Income
NZ$19.2m
CAGR 3-Years
12%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Cannasouth Ltd
NZX:CBD
Operating Income
-NZ$8.7m
CAGR 3-Years
-37%
CAGR 5-Years
-104%
CAGR 10-Years
N/A
G
Greenfern Industries Ltd
NZX:GFI
Operating Income
-NZ$1.4m
CAGR 3-Years
-4%
CAGR 5-Years
-66%
CAGR 10-Years
N/A
No Stocks Found

Rua Bioscience Ltd
Glance View

Market Cap
8.6m NZD
Industry
Pharmaceuticals

Rua Bioscience Ltd. operates as a pharmaceutical company that develops medical cannabis products. The company is headquartered in Gisborne, Gisborne. The company went IPO on 2020-10-22. The firm operate in the medicinal cannabis sector commercially and is focused on producing cannabinoid derived medicines. The firm is also focusing on cultivating and developing quality-assured medicinal cannabis as active pharmaceutical ingredients.

RUA Intrinsic Value
0.001 NZD
Overvaluation 96%
Intrinsic Value
Price

See Also

What is Rua Bioscience Ltd's Operating Income?
Operating Income
-4.6m NZD

Based on the financial report for Jun 30, 2024, Rua Bioscience Ltd's Operating Income amounts to -4.6m NZD.

What is Rua Bioscience Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
-18%

Over the last year, the Operating Income growth was 62%. The average annual Operating Income growth rates for Rua Bioscience Ltd have been 10% over the past three years , -18% over the past five years .

Back to Top